Guest guest Posted November 12, 2003 Report Share Posted November 12, 2003 How can be possible someone so stupid as Hellen got a degree? And, how much is she paid for saying such things? Her answers about LDN are getting longer (15 lines, this one). But still… Same lack of utility, No additional information, Nothing more that anyone else could have said about Naltrexone knowing Nothing about it!!! I can forgive anyone for saying similar things but not from someone that shows some sort of authority. Qualified people should take even more caution when giving public statements like this. The consideration about safety of trying a new drug… EVERYBODY KNOWS doesn't really apply to Naltrexone!!! Why is she insisting saying this stupid thing discouraging people from trying it??? and she is the only one in the planet rising concerns about LDN safety. About the other person, this … She is even more pathetic than Hellen because she is bouncing up her stupid answer at the LDN question like if it was revealing something extraordinary. But it is not. It is just an unnecessary and NOT professional personal consideration. PS: Then, what is Hellen consideration about people experimenting new drugs and undergoing medical trial???? Perhaps she would suggest medical trials only with drugs that have been already tested by a medical trial…. --- In low dose naltrexone , " LarryGC " <larrygc@s...> wrote: > OH, you should see the other messages, on MS People! She jumped all over me! Welcome to the club. > > She sent that same message to Marjees, MS People and MSTogetherness. > > > ----- Original Message ----- > From: > low dose naltrexone > Sent: Wednesday, November 12, 2003 09:22 > Subject: [low dose naltrexone] I dont get it > > > Recently I left LeeLee's group because insists that LDN is > simply placebo effect, and her and another member practically > insisted that trying LDN caused her to go into a serious > exacerbation. After I left, posted this piece. Its amazing how > there are people out there for some reason who just want to keep > others uninformed: > > IN LIGHT OF ALL OF THE RECENT LDN AND MS TALK, I CAME UPON AN ARTICLE > IN THIS MONTHS MSFOCUS MAGAZINE WHERE A PERSON WROTE IN A QUESTION > ABOUT LDN AND IT WAS ANSWERED..I'M TYPING IT INTO OUR BOARDS SINCE I > DON'T HAVE A SCANNER SO THAT ALL OF YOU MIGHT HAVE A BIT MORE INSIGHT > TO THIS MEDICATION THAT YOU ARE HEARING A LOT OF HOUPLA ABOUT...SO > HERE IT IS... > > Q. LOW DOSE NALTREXONE > > I WOULD BE GRATEFUL IF YOU COULD PROVIDE SOME INFORMATION ABOUT LOW > DOSE NALTREXONE FOR TREATMENT OF MULTIPLE SCLEROSIS. > > A. > MANY PATIENTS ARE INQUIRING ABOUT LOW-DOSE NALTREXONE FOR MS. > NALTREXONE IS COMMERCIALLY AVAILABLE UNDER THE NAME REVIA. THIS > PRODUCT IS A NARCOTIC ANTAGONIST, MEANING THAT IT BLOCKS THE ACTION > OF NARCOTICS AND ALCOLHOL IN THE BODY. NALTREXONE CAN CAUSE > INSOMNIA, NERVOUSNESS, HEADACHE, ABDOMINAL CRAMPING, NAUSEA, > VOMITING, KIDNEY AND LIVER DAMAGE. IT IS CONTRAINDICATED FOR USE > WITH ALL NARCOTICS (OXYCONTIN, DURAGESIC,PERCOSCET, LORTAB, ETC) > THIS DRUG IS BEING MARKETED AS A PRODUCT THAT CAN REDUCE MS RELAPSES, > FATIGUE AND SPASMS. NO PUBLISHED CLINICAL DATA EXISTS ON THIS > PRODUCT. CONTROLLED, RANDOMIZED,, CLINICAL TRIALS ARE NEEDED TO > EXAMINE THE USE OF LOW-DOSE NALTREXONE IN MS. AT THIS POINT, IT > SHOULD NOT BE CONSIDERED AN ALTERNATIVE FOR THE CURRENT DISEASE > MODIFYING THERAPIES:BETASERON, AVONEX, COPOXONE, REBIF OR > NOVANTRONE. MY ADVICE FOR PATIENTS IS TO AVOIDE PRODUCTS THAT LACK > PROOF OF SAFETY AND EFFICACY. > ELLEN GUTHRIE, PHARM. D. > > THE ONLY REASON FOR ME POSTING THIS INFORMATION IS FOR THE PURPOSE OF > POSTING INFORMATION AND GIVING US THE POWER OF KNOWLEDGE THAT ALLOWS > US TO MAKE INFORMED DECISIONS WITH OUR DOCTORS FOR OURSELVES...LISA > > (from LeeLee's MS group ) > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.